These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 24687730)
1. Specific targeting of atherosclerotic plaques in ApoE(-/-) mice using a new Camelid sdAb binding the vulnerable plaque marker LOX-1. De Vos J; Mathijs I; Xavier C; Massa S; Wernery U; Bouwens L; Lahoutte T; Muyldermans S; Devoogdt N Mol Imaging Biol; 2014 Oct; 16(5):690-8. PubMed ID: 24687730 [TBL] [Abstract][Full Text] [Related]
2. SPECT and fluorescence imaging of vulnerable atherosclerotic plaque with a vascular cell adhesion molecule 1 single-chain antibody fragment. Liu C; Zhang X; Song Y; Wang Y; Zhang F; Zhang Y; Zhang Y; Lan X Atherosclerosis; 2016 Nov; 254():263-270. PubMed ID: 27680307 [TBL] [Abstract][Full Text] [Related]
3. Detection of atherosclerotic plaques in ApoE-deficient mice using (99m)Tc-duramycin. Liu Z; Larsen BT; Lerman LO; Gray BD; Barber C; Hedayat AF; Zhao M; Furenlid LR; Pak KY; Woolfenden JM Nucl Med Biol; 2016 Aug; 43(8):496-505. PubMed ID: 27236285 [TBL] [Abstract][Full Text] [Related]
4. PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments. Blykers A; Schoonooghe S; Xavier C; D'hoe K; Laoui D; D'Huyvetter M; Vaneycken I; Cleeren F; Bormans G; Heemskerk J; Raes G; De Baetselier P; Lahoutte T; Devoogdt N; Van Ginderachter JA; Caveliers V J Nucl Med; 2015 Aug; 56(8):1265-71. PubMed ID: 26069306 [TBL] [Abstract][Full Text] [Related]
5. In vivo molecular imaging of atherosclerotic lesions in ApoE-/- mice using VCAM-1-specific, 99mTc-labeled peptidic sequences. Dimastromatteo J; Broisat A; Perret P; Ahmadi M; Boturyn D; Dumy P; Fagret D; Riou LM; Ghezzi C J Nucl Med; 2013 Aug; 54(8):1442-9. PubMed ID: 23719858 [TBL] [Abstract][Full Text] [Related]
6. ⁹⁹mTc-labeled single-domain antibody EG2 in targeting epidermal growth factor receptor: an in-vitro and mouse model in-vivo study. Li C; Wen B; Wang L; Feng H; Xia X; Ding Z; Gao B; Zhang Y; Lan X Nucl Med Commun; 2015 May; 36(5):452-60. PubMed ID: 25591074 [TBL] [Abstract][Full Text] [Related]
7. A Comparison of [ Hu Y; Liu G; Zhang H; Li Y; Gray BD; Pak KY; Choi HS; Cheng D; Shi H Mol Imaging Biol; 2018 Apr; 20(2):249-259. PubMed ID: 28785938 [TBL] [Abstract][Full Text] [Related]
8. Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance. Li D; Patel AR; Klibanov AL; Kramer CM; Ruiz M; Kang BY; Mehta JL; Beller GA; Glover DK; Meyer CH Circ Cardiovasc Imaging; 2010 Jul; 3(4):464-72. PubMed ID: 20442371 [TBL] [Abstract][Full Text] [Related]
12. The GEM-handle as convenient labeling strategy for bimodal single-domain antibody-based tracers carrying Declerck NB; Huygen C; Mateusiak L; Stroet MCM; Hernot S Front Immunol; 2023; 14():1285923. PubMed ID: 38035094 [TBL] [Abstract][Full Text] [Related]
13. Atherosclerosis plaque heterogeneity and response to therapy detected by in vivo molecular imaging of matrix metalloproteinase activation. Razavian M; Tavakoli S; Zhang J; Nie L; Dobrucki LW; Sinusas AJ; Azure M; Robinson S; Sadeghi MM J Nucl Med; 2011 Nov; 52(11):1795-802. PubMed ID: 21969358 [TBL] [Abstract][Full Text] [Related]
14. In vivo MRI detection of carotid atherosclerotic lesions and kidney inflammation in ApoE-deficient mice by using LOX-1 targeted iron nanoparticles. Wen S; Liu DF; Cui Y; Harris SS; Chen YC; Li KC; Ju SH; Teng GJ Nanomedicine; 2014 Apr; 10(3):639-49. PubMed ID: 24103305 [TBL] [Abstract][Full Text] [Related]
15. Niclosamide downregulates LOX-1 expression in mouse vascular smooth muscle cells and changes the composition of atherosclerotic plaques in ApoE Yang T; Minami M; Yoshida K; Nagata M; Yamamoto Y; Takayama N; Suzuki K; Miyata T; Okawa M; Miyamoto S Heart Vessels; 2022 Mar; 37(3):517-527. PubMed ID: 34807278 [TBL] [Abstract][Full Text] [Related]
16. Selective Imaging of Vascular Endothelial Growth Factor Receptor-1 and Receptor-2 in Atherosclerotic Lesions in Diabetic and Non-diabetic ApoE Tekabe Y; Johnson LL; Rodriquez K; Li Q; Backer M; Backer JM Mol Imaging Biol; 2018 Feb; 20(1):85-93. PubMed ID: 28421362 [TBL] [Abstract][Full Text] [Related]
17. Hexarelin attenuates atherosclerosis via inhibiting LOX-1-NF-κB signaling pathway-mediated macrophage ox-LDL uptake in ApoE Cheng XL; Ding F; Wang DP; Zhou L; Cao JM Peptides; 2019 Nov; 121():170122. PubMed ID: 31386895 [TBL] [Abstract][Full Text] [Related]
18. Detection of early stage atherosclerotic plaques using PET and CT fusion imaging targeting P-selectin in low density lipoprotein receptor-deficient mice. Nakamura I; Hasegawa K; Wada Y; Hirase T; Node K; Watanabe Y Biochem Biophys Res Commun; 2013 Mar; 433(1):47-51. PubMed ID: 23485468 [TBL] [Abstract][Full Text] [Related]
19. Targeting P-selectin by gallium-68-labeled fucoidan positron emission tomography for noninvasive characterization of vulnerable plaques: correlation with in vivo 17.6T MRI. Li X; Bauer W; Israel I; Kreissl MC; Weirather J; Richter D; Bauer E; Herold V; Jakob P; Buck A; Frantz S; Samnick S Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1661-7. PubMed ID: 24903095 [TBL] [Abstract][Full Text] [Related]